ACAnkanee Chanakul

Ankanee Chanakul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ankanee Chanakul has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Boonyapohn Chatpaitoon

    Department of Pediatrics, Faculty of Medicine Chulalongkorn University, King Chulalongkorn Memorial Hospital Bangkok Thailand

    1 shared publication
  • Lalida Kongkiattikul

    Division of pulmonology and critical care, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand

    1 shared publication
  • Nataruks Chaijitraruch

    1–6Department of Pediatrics, King Chulalongkorn Memorial Hospital, Bangkok, Thailand

    1 shared publication
  • Parichat Khaosut

    Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand

    1 shared publication
  • Pornpimol Rianthavorn

    Division of Nephrology, Department of Pediatrics, Faculty of Medicine Chulalongkorn University, King Chulalongkorn Memorial Hospital Bangkok Thailand

    1 shared publication
  • Rujipat Samransamruajkit

    Division of Critical Care Medicine, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, chula.ac.th

    1 shared publication

Latest Publications

  • Clinical characteristics and risk factors for kidney involvement in children with immunoglobulin A vasculitis

    by Boonyapohn Chatpaitoon, Pornpimol Rianthavorn, Ankanee Chanakul, Parichat Khaosut

    Background: Immumoglobulin A (IgA) vasculitis (IgAV), formerly known as Henoch–Schönlein purpura (HSP), is a self‐limiting systemic vasculitis in children. Kidney involvement is associated with a long‐term unfavorable outcome and can lead to significant morbidity. This study was conducted to describe the clinical and laboratory characteristics of childhood IgAV with kidney involvement and to identify risk factors associated with IgAV nephritis (IgAVN). Methods: This was an ambidirectional descriptive study of 77 children with IgAV. All demographic data, clinical features, and laboratory tests were collected from electronic medical records from January 2010 to December 2022. Risk factors for kidney involvement in IgAV were assessed using multivariate logistic regression. Kaplan–Meier survival analysis was used to calculate the time to commencement of kidney involvement. Results: Twenty‐five children (32.4% of the IgAV patients) developed IgAVN. The common findings in IgAV with kidney involvement were microscopic hematuria (100%), nephrotic range proteinuria (44%), and non‐nephrotic range proteinuria (40%). Multivariate logistic regression showed that age greater than 10 years (adjusted hazard ratio, AHR 4.66; 95% confidence interval, CI, 1.91–11.41; p = 0.001), obesity (body mass index, BMI, z ‐score ≥ +2 standard deviations, SDs) (AHR 3.59; 95% CI 1.41–9.17; p = 0.007), and hypertension at onset (AHR 4.78; 95% CI 1.76–12.95; p = 0.002) were associated significantly with kidney involvement. During follow up, most IgAV patients developed nephritis within the first 9 months. Conclusion: Age greater than 10 years, obesity, and hypertension at presentation were predictive factors for IgAVN. Our study emphasized that IgAV patients with risk factors should be closely monitored for at least 1 year after the onset of the disease.


  • Incidence of healthcare‐associated urinary tract infections in Thai children

    by Wimwipa Mongkonsritragoon, Suvaporn Anugulruengkitt, Ankanee Chanakul

    Background: Urinary tract infection is one of the commonest types of healthcare‐associated infections. There are currently limited data regarding the incidence and characteristics of healthcare‐associated urinary tract infections (HA‐UTIs) in children. This study was conducted to determine the incidence of HA‐UTIs and their characteristics and associated risk factors.Methods: A case‐control study was performed from 2016 to 2020 on children under 15 years old who were diagnosed with HA‐UTI. Patients who had HA‐UTI were compared with non‐UTI patients. The incidence rate of HA‐UTIs was calculated and reported as events per 1000 patient days. Potential associated risk factors were analyzed using multivariate logistic regression.Results: Eighty cases and 80 controls were included in the study. The incidence of HA‐UTIs was 0.32 events per 1000 patient days. The median time to UTI was 18 days. The most common causative organism was Escherichia coli (43.2%) and the rates of third‐generation cephalosporin resistance and carbapenem resistance were 75.6% and 4.9%, respectively. Admission longer than 7 days (OR = 21.61, 95% CI: 6.30–74.11; p < 0.001), neurogenic bladder (OR = 26.24, 95% CI: 3.77–182.87; p < 0.001), mechanical ventilation (OR = 3.60, 95% CI: 1.23–10.54; p = 0.019), and immunosuppressants (OR = 2.59; 95% CI: 1.01–6.60; p = 0.047) were the risk factors significantly associated with HA‐UTIs.Conclusions: The incidence of HA‐UTIs was low in this single‐center experience. Identifying patients with the risk factor is imperative for preventing the development of HA‐UTIs.


  • Open Access

    Low bone mineral density in Thai children with systemic lupus erythematosus: prevalence and risk factors

    by Ankanee Chanakul, Suriyaphon Khunrattanaphon, Tawatchai Deekajorndech

    Background: Improvement of disease recognition and management has increased the survival of children with systemic lupus erythematosus (SLE), but has shifted the morbidity focus toward long-term complications, such as low bone mass and osteoporosis. Studies in adults with SLE show older age, chronic inflammation, and corticosteroid therapy are risk factors for low bone mineral density (BMD) and osteoporosis. Objectives: To determine the prevalence of and identify risk factors associated with low BMD in Thai children with SLE. Methods: We conducted a retrospective review of demographic data and clinical variables for a cohort of 60 Thai children with SLE who underwent 2 dual-energy X-ray absorptiometry (DXA) at their initial examination and later follow-up. We considered a BMD z score ≤ −2.0 to indicate low BMD. Binary logistic regression was used to assess risk factors potentially associated with low BMD. Results: The prevalence of low BMD at the first visit was 40% and increased to 55% over follow-up. We found a significantly decreased hip BMD z score (median difference −0.25, 95% confidence interval [CI] −0.40 to −0.05; P = 0.016) and lumbar BMD z score (median difference −0.49, 95% CI −0.69 to −0.28; P < 0.001) over time. The cumulative steroid dose tended to be higher for patients with low BMD (adjusted odds ratio [OR] = 1.08, 95% CI 1.00 to 1.17; P = 0.050). Conclusion: Low BMD has a 40% prevalence in Thai children newly diagnosed with SLE and progresses significantly over time. Higher cumulative corticosteroid dose tended to be associated with a low BMD, but we did not find a significant risk in this small sample.


  • Open Access

    Therapeutic Plasma Exchange with Continuous Renal Replacement Therapy for Pediatric Acute Liver Failure: A Case Series from Thailand

    by Voranush Chongsrisawat, Rujipat Samransamruajkit, Sirawut Trepatchayakorn, Nataruks Chaijitraruch, Ankanee Chanakul, Lalida Kongkiattikul

    Pediatric acute liver failure (PALF) is a life-threatening condition. Extracorporeal support has been applied for toxic metabolite clearance and serves as a bridging therapy to liver transplantation (LT) or to the regeneration of the liver, but evidence for treatment approaches is still lacking in the pediatric population. We aim to report our experience on therapeutic plasma exchange with high-volume continuous renal replacement therapy (TPE + HV-CRRT) as a promising supportive treatment for PALF. A total of eight PALF cases aged 9 months to 14 years, weighing 10–50 kg., who were admitted to PICU King Chulalongkorn Memorial Hospital, Thailand and treated with TPE + HV-CRRT from January 2016 to September 2019 were reviewed. Patient demographic data, indications, technical aspects, and clinical outcomes were recorded. All patients who underwent TPE + HV-CRRT showed clinical improvement regarding serum bilirubin levels and coagulation studies after the therapy. Complications from the therapy were hemodynamic instability, symptomatic fluid overload, and bleeding from catheter sites. Among these, 6 (75%) patients survived with 4 (50%) successful LTs and 2 (25%) spontaneous recovery. Two children (25%) died while on the transplantation list. TPE + HV-CRRT can be used safely as a bridging therapy in children with PALF. As opposed to the adult population, higher volume of TPE or higher blood flow rate in pediatric patients might associate with hemodynamic instability during the procedure. Trepatchayakorn S, Chaijitraruch N, Chongsrisawat V, Chanakul A, Kongkiattikul L, Samransamruajkit R. Therapeutic Plasma Exchange with Continuous Renal Replacement Therapy for Pediatric Acute Liver Failure: A Case Series from Thailand. Indian J Crit Care Med 2021;25(7):812–816.